Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. In the Russian Federation, as in the whole world, the number of patients with type 2 diabetes mellitus (DM2) continues to increase. Also, there is currently an increase in the number of patients with hypothyroidism. The prevalence of hypothyroidism among DM2 patients is higher than in the general population. A decrease in the function of the thyroid gland in persons with DM2 aggravates the already existing disorders of carbohydrate and lipid metabolism, and insulin resistance. Objective: to assess the relationship between the level of resistin and hormone-metabolic parameters in patients with hypothyroidism, DM2 and their combination. Methods. Three groups of women were examined: 42 women with primary hypothyroidism, 38 women with T2DM and 39 women with a combination of DM2 and primary hypothyroidism. All the subjects underwent an anthropometric examination, the parameters of carbohydrate and lipid metabolism, and the level of resistin were examined. The results of a survey of 35 apparently healthy women, divided into older and younger groups, were used as controls. Results. Women with DM2 and its combination with hypothyroidism were found to have hyperglycemia and hyperinsulinemia. An increase in total cholesterol, triglyceride levels, and coefficient of atherogenicity was found in all groups of the examined. Patients with hypothyroidism and patients with DM2 have elevated resistin levels. Conclusion. Women with DM2 and its combination with hypothyroidism showed insulin resistance, which was accompanied by compensatory hyperinsulinemia. A significant increase in the level of resistin was found in patients with hypothyroidism and patients with DM2. Atherogenic dyslipidemia was found in all patients. Resistin affects the development of insulin resistance in patients with DM2 and hypothyroidism.

Full Text

Restricted Access

About the authors

Tatyana V. Verbovoy

Samara State Medical University

Samara, Russia

T. V Lomonova

Samara State Medical University

Email: t.lomonova@mail.ru
Postgraduate student, Department of Endocrinology 89, Chapaevskaya str., Samara 443099, Russian Federation

References

  1. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 8-й выпуск. М, 2017. 112 с. Doi: 10.14341/ DM20171S8. doi: 10.14341/dm20171s8.
  2. Mohamed G.A., Elsayed A.M. Subclinical hypothyroidism ups the risk of vascular complications in type 2 diabetes. Alexandr J Med. 2017;53:285-88.
  3. Song F., Bao C., Deng M., et al. The prevalence and determinants of hypothyroidism in hospitalized patients with type 2 diabetes mellitus. Endocrin. 2017;55:179-85. doi: 10.1007/s12020-016-1095-2.
  4. Perros P., McCrimmon R.J., Shaw G., et al. Frequency of thyroid dysfunction in diabetic patients. Value of annual screening. Diabet Med. 2009;32:622. doi: 10.1111/j.1464-5491.1995. tb00553.x.
  5. Дубинина И.И., Берстнева С.В. Заместительная терапия левотироксином при сахарном диабете и гипотиреозе. Эффективная фармакотерапия. 2018;8:28-33.
  6. Дедов И.И., Мельниченко Г.А., Бутрова С.А. Жировая ткань как эндокринный орган. Ожирение и метаболизм. 2006;1:6-13.
  7. Петунина Н.А., Трухина Л.В. Болезни щитовидной железы. М., 2011. 216 с., ил.
  8. Петрик Г.Г. Показатели метаболизма и гемостаза у пациентов с сахарным диабетом 2 типа и гипотиреозом. Клиническая и экспериментальная тиреоидология. 2011;7(3):62-6.
  9. Терещенко И.В., Каменских Я.А., Суслина А.А., Каюшев П.Е. Дислипидемия у больных с сахарным диабетом 2-го типа в сочетании с гипотиреозом и желчно-каменной болезнью. Материалы XIX Международной научной конференции «ОНКОЛОГИЯ - XXI ВЕК». 2015. С. 227-32.
  10. Капралова И.Ю. Взаимосвязь адипокинов и гормонально-метаболических показателей у больных гипотиреозом. Дисс. канд. мед. наук. Самара, 2017.
  11. Вербовой А.Ф., Скудаева Е.С., Пашенцева А.В. Уровни резистина, адипонектина и инсулинорезистентности у пациентов с разной степенью нарушений углеводного обмена. Ожирение и метаболизм. 2011;3:57-60.
  12. Пашенцева А.В. Роль лептина и резистина в развитии инсулинорезистентности у больных сахарным диабетом 2 типа. Diss. Cand. of Med. Sciences. Самара, 2012.
  13. Альтшулер Н.Э., Петунина Н.А., Николаев А.П., Чернышова Т.В. Сравнительный анализ концентрации гормонов жировой ткани, показателей липидного обмена и инсулинорезистентности при субклиническом гипотиреозе в зависимости от наличия/отсутствия заместительной терапии левотироксином.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies